Beckman Coulter Dx Asia Pacific

Ovarian cancer is often diagnosed late because its symptoms can be subtle, non-specific, and easily overlooked. More than 70% of women are diagnosed at an advanced stage, where outcomes become significantly more challenging. Common symptoms may include: 🎈 Persistent bloating ⚡ Pelvic or abdominal pain 🍽️ Feeling full quickly (early satiety) 🚻 Urinary urgency or frequency As conversations continue around World Ovarian Cancer Day and the theme “No Woman Left Behind,” the role of diagnostics in supporting earlier clinical insight and disease monitoring remains more important than ever. #WorldOvarianCancerDay #NoWomanLeftBehind #OvarianCancerAwareness #WomensHealth

Ovarian cancer remains one of the most serious gynecological cancers, with more than 70% of women diagnosed at an advanced stage due to subtle, non-specific symptoms and limited screening options. As we continue the conversation around World Ovarian Cancer Day, raising awareness and enabling timely investigation remain critical to improving outcomes. Early recognition can make all the difference.💙 #WorldOvarianCancerDay #NoWomanLeftBehind #OvarianCancerAwareness #WomensHealth

Global STI rates continue to rise, with the WHO reporting 8 million new syphilis infections in 2022 and 230,000 syphilis‑related deaths—a trend that continues to strain clinical and public‑health systems worldwide.🌍 Join us May 19, 2026 at 1:00 ET 🗓️ for “Modernizing STI Surveillance and Diagnostics: Lab Driven Strategies for a Changing Public Health Landscape,” a live webinar with Dr. Jeffrey Klausner, where he will discuss how integrated laboratory data across serologic, antigen‑based, and molecular testing 🔬 enhance accurate interpretation, guide clinical pathways 🩺, and strengthen public‑health surveillance across care settings. Register here 👉 https://bit.ly/3PnWHFz. P.S. Continuing education credit is available for eligible participants 🎓

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that often remains difficult to recognize in its early stages due to its multisystem and unpredictable nature. Yet behind every delayed diagnosis is a patient navigating symptoms that are too often unseen or misunderstood. 🌍 ~3.4 million people worldwide are living with SLE 📈 ~400,000 new cases are diagnosed each year 👩 Women remain disproportionately affected, particularly during reproductive years As we recognize World Lupus Day and the theme “Make Lupus Visible,” we also recognize the critical role diagnostics play in transforming awareness into actionable clinical insight. We remain committed to empowering laboratories with scalable diagnostic solutions that help make the invisible visible — enabling earlier detection, better monitoring, and improved patient care. Earlier insight starts in the lab. 🔬💜 #WorldLupusDay #MakeLupusVisible #LupusAwareness #AutoimmuneDisease #Lupus #LupusNephritis

Lupus is often called the “invisible disease” — complex, multisystem, and difficult to recognize early. Yet nearly 3.4 million people worldwide are living with systemic lupus erythematosus (SLE), with many still facing delayed diagnosis and under recognition. This World Lupus Day, we recognize the critical role of diagnostics in turning awareness into earlier insight, better monitoring, and improved patient care. #WorldLupusDay #MakeLupusVisible #LupusAwareness #AutoimmuneDisease

Step into the world of hematology with our latest case study and uncover how advanced insights can make a difference in patient outcomes. Explore the clinical presentation and test results powered by the DxH 900 and DxH 690T. Can you identify the diagnosis? 🩺 Dive into more real-world cases here 👉 https://bit.ly/3SbiCPe #Hematology #CaseStudy #InnovationInMedicine #DxH900 #BeckmanCoulter #Blood #Leukemia #Sepsis

Malaria continues to pose a significant health challenge across APAC, with millions at risk and the growing threat of drug-resistant strains demanding renewed focus and action. According to the WHO World Malaria Report 2025, malaria accounted for an estimated 282 million cases and 610,000 deaths in 2024. Early and accurate diagnosis remains critical. Advanced diagnostics—including hematology insights—can support early suspicion, timely detection, and better clinical decision-making. At Beckman Coulter, we are committed to advancing diagnostic innovation that supports laboratories and healthcare systems in improving patient outcomes across the region. Learn more about our hematology solutions: https://bit.ly/3EJBRoC Together, through innovation and collaboration, we can accelerate the fight against malaria. 🌍🦟 #WorldMalariaDay #EndMalaria #Hematology #APACHealthcare

Malaria continues to be a major global health challenge—causing nearly 250 million infections and over 600,000 deaths each year, with children among the most vulnerable. Nearly half of the world’s population remains at risk. This World Malaria Day, explore a compelling case study of Plasmodium malariae in a 42-year-old patient—highlighting the complexities of diagnosis, the role of vectors, the growing impact of climate change, and ongoing advancements in diagnostics and vaccines. As malaria remains difficult to identify in its early stages, advanced diagnostics including hematology insights play a critical role in raising suspicion and supporting timely detection. Read the full case and discover one patient’s journey to diagnosis, along with the broader challenges and hope for eradication: https://bit.ly/3YlGl0P #WorldMalariaDay #EndMalaria #Malaria #Hematology #MalariaDiagnosis

Malaria remains one of the world’s most pressing infectious diseases—with 282 million cases and 610,000 deaths reported globally in 2024. Behind these numbers lies a critical reality: progress is fragile, and emerging threats like drug resistance risk reversing hard-earned gains. This World Malaria Day is a call to act—not just to sustain efforts, but to reinvest in health systems, reimagine solutions through innovation, and reignite global commitment to elimination. Diagnostics play a pivotal role in this journey. From enabling early detection to strengthening surveillance and disease management, timely and reliable diagnostic insights are essential to advancing malaria control strategies. 🔬 Ending malaria is possible—but only through collective, sustained action. Together, we can move closer to a malaria-free world. 🌍🦟 Learn more: https://bit.ly/3EJBRoC #WorldMalariaDay #EndMalaria #InfectiousDiseases #DrugResistance

On World Malaria Day, we reaffirm our commitment to accelerating the fight against malaria. While progress has been made, malaria continues to pose a significant health burden. Globally, there are an estimated 249 million cases and over 600,000 deaths each year, underscoring the urgent need for timely diagnosis and effective disease management. In many settings, hematology analyzers play a critical role in early screening—flagging abnormalities such as changes in platelet count and red blood cell parameters that can support suspicion of malaria and prompt further confirmatory testing. At Beckman Coulter, we are committed to pioneering hematology that deliver reliable insights—supporting faster clinical decisions and improved patient outcomes. Together, through innovation and collaboration, we can move closer to a malaria-free future. #WorldMalariaDay #Malaria #Hematology